Page last updated: 2024-10-27

fluconazole and Community Acquired Infection

fluconazole has been researched along with Community Acquired Infection in 9 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"Most patients with sepsis or septic shock from a urinary source have complicated urinary tract infection."2.49Urinary tract infection. ( Nicolle, LE, 2013)
"Treatment with fluconazole was successful."1.43Community acquired fungemia caused by Candida pulcherrima: diagnostic contribution of MALDI-TOF mass spectrometry. ( Deconinck, L; Melliez, H; Meybeck, A; Patoz, P; Pradier, M; Senneville, E, 2016)
"Fluconazole was more frequently used in medium size hospitals than in the large ones (60."1.38[Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006-2010]. ( Alvarez-Lerma, F; Gimeno-Costa, R; Gracia-Arnillas, MP; Insausti-Ordeñana, J; López-Pueyo, MJ; Olaechea-Astigarraga, PM; Otal-Entraigas, JJ; Palomar-Martínez, M; Seijas-Betolaza, I, 2012)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's1 (11.11)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Oladele, RO1
Ettu, AO1
Medugu, N1
Habib, A1
Egbagbe, E1
Osinaike, T1
Makanjuola, OB1
Ogunbosi, B1
Irowa, OO1
Ejembi, J1
Uwaezuoke, NS1
Adeleke, G1
Mutiu, B1
Ogunsola, F1
Rotimi, V1
Wheeler, DJ1
Cascino, T1
Sharpe, BA1
Connor, DM1
Nicolle, LE1
Deconinck, L1
Meybeck, A1
Pradier, M1
Patoz, P1
Melliez, H1
Senneville, E1
Chuang, TY1
Yeh, CY1
Ko, SW1
Lin, CJ1
Lee, SW1
Hsueh, PR1
Olaechea-Astigarraga, PM1
Alvarez-Lerma, F1
Palomar-Martínez, M1
Insausti-Ordeñana, J1
López-Pueyo, MJ1
Seijas-Betolaza, I1
Otal-Entraigas, JJ1
Gimeno-Costa, R1
Gracia-Arnillas, MP1
Cheng, YR1
Lin, LC1
Young, TG1
Liu, CE1
Chen, CH1
Tsay, RW1
Lin, A1
Stout, JE1
Rihs, JD1
Vickers, RM1
Yu, VL1
Jandourek, A1
Brown, P1
Vazquez, JA1

Reviews

1 review available for fluconazole and Community Acquired Infection

ArticleYear
Urinary tract infection.
    Critical care clinics, 2013, Volume: 29, Issue:3

    Topics: Acute Disease; Aminoglycosides; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Catheters,

2013

Other Studies

8 other studies available for fluconazole and Community Acquired Infection

ArticleYear
Antibiotic Guidelines for Critically Ill Patients in Nigeria.
    West African journal of medicine, 2023, Sep-28, Volume: 40, Issue:9

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Community-Acqu

2023
When the Script Doesn't Fit: An Exercise in Clinical Reasoning.
    Journal of general internal medicine, 2017, Volume: 32, Issue:7

    Topics: Adult; Antifungal Agents; Chest Pain; Coccidioidomycosis; Community-Acquired Infections; Diagnosis,

2017
Community acquired fungemia caused by Candida pulcherrima: diagnostic contribution of MALDI-TOF mass spectrometry.
    Annals of clinical microbiology and antimicrobials, 2016, Mar-08, Volume: 15

    Topics: Antifungal Agents; Candida; Candidemia; Candidiasis; Community-Acquired Infections; Fluconazole; Hum

2016
Fatal case of community-acquired empyema thoracis and candidemia caused by Candida albicans.
    Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:2

    Topics: Antifungal Agents; Candida albicans; Candidemia; Community-Acquired Infections; Empyema; Fluconazole

2011
[Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006-2010].
    Enfermedades infecciosas y microbiologia clinica, 2012, Volume: 30, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Community-Acquired Infections; Critical Illness; Cro

2012
Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2006, Volume: 39, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; APACHE; Candida; Candidiasis;

2006
Improved Legionella selective media by the addition of fluconazole: results of in vitro testing and clinical evaluation.
    Diagnostic microbiology and infectious disease, 1999, Volume: 34, Issue:3

    Topics: Anisomycin; Antifungal Agents; Bacteriological Techniques; Candida albicans; Community-Acquired Infe

1999
Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clotrimazole; Community-Acquired Infections

1999